Shena Oneill
Family · Missoula, MTNPI 1346984408
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,546 of the $4,023 with a category attached, or 63.3%. 17 manufacturers reported payments, led by Axonics, Inc. at 47.7% of the total. Reporting peaked in 2024 at $2,100 and has fallen 51.2% since, to $1,025 in 2025. Among family clinicians in MT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 84 payments — averaging $47.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$2K
- AbbVie$418
- Procept Biorobotics Corporation$375
- Johnson & Johnson$351
- Astellas Pharma US Inc$281
- Dendreon Pharmaceuticals LLC$166
- plus $515 from 11 others
What the payments were for
- Travel & lodging$1,38834%
- Food & beverage$2,54663%
- Education$892%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 12 | $1,917 |
| AbbVie | 21 | $418 |
| Procept Biorobotics Corporation | 3 | $375 |
| Johnson & Johnson | 11 | $351 |
| Astellas Pharma US Inc | 7 | $281 |
| Dendreon Pharmaceuticals LLC | 2 | $166 |
| Pfizer | 7 | $118 |
| Sumitomo Pharma America, Inc. | 5 | $93 |
| 180 Medical, Inc. | 4 | $90 |
| Ambu Inc. | 3 | $53 |
| Laborie Medical Technologies Corp. | 2 | $37 |
| Immunitybio, Inc. | 2 | $33 |
| Endo Pharmaceuticals Inc. | 1 | $24 |
| Teleflex LLC | 1 | $19 |
| Tolmar, Inc. | 1 | $18 |
| Boston Scientific | 1 | $17 |
| Coloplast | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$1,427
- AquaBeam Robotic System$227
- PROVENGE$150
- Erleada$142
How this compares
$4,023 in reported general payments places this provider in the 95th percentile of 481 family providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 187 | $133,838 |
| MyrbetriqMirabegron | 211 | $122,106 |
| OrgovyxRelugolix | 17 | $44,470 |
| Estradiol | 92 | $6,346 |
| Methenamine Hippurate | 55 | $3,635 |
| Tamsulosin Hcl | 257 | $3,398 |
| Solifenacin Succinate | 65 | $2,319 |
| Finasteride | 94 | $1,307 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 70 | $1,294 |
| Potassium Citrate ErPotassium Citrate | 22 | $1,098 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 16 | $966 |
| Cephalexin | 139 | $835 |
| Oxybutynin Chloride ErOxybutynin Chloride | 32 | $483 |
| Doxycycline Hyclate | 12 | $436 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 58 | $380 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa, Orgovyx | $93 | $178,308204 claims |
| Astellas Pharma US IncMyrbetriq | $281 | $122,106211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 481 family providers in Montana.
Other family in Missoula
- Michelle Weaver KnowlesMissoula$14K
- Chelsey MillerMissoula$3K
- Nicole SwartzMissoula$3K
- Tiffany FordMissoula$3K
- Matt McNuttMissoula$3K
- Mackenzie WestphalMissoula$3K
- Kari DebooMissoula$2K
- Sarah SlaterMissoula$2K
- Megan MorganMissoula$2K
- Susan McGeeMissoula$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.